1. Activity of ALK Inhibitors in Renal Cancer with ALK Alterations: A Systematic Review
   Giovanni Maria Iannantuono et al, 2022, International Journal of Molecular Sciences CrossRef
2. SEL1L3 as a link molecular between renal cell carcinoma and atherosclerosis based on bioinformatics analysis and experimental verification
   Haoyuan Wang et al, 2023, Aging CrossRef
3. Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
   Liping Shan et al, 2020, Frontiers in Oncology CrossRef